German Lab Demonstrates Feasibility to Detect SARS-Coronavirus-2 (SARS-CoV-2) Using Hologic’s Panther Fusion® System
A molecular assay for detecting the novel coronavirus SARS-CoV-2 (previously 2019-nCoV) on the automated Panther Fusion® system has been developed by investigators at Hannover Medical School in Germany, Hologic (Nasdaq: HOLX) announced today. The preclinical assay is described online in the Journal of Clinical Virology.1
The Open Access™ functionality on the Panther Fusion® system allows accredited medical laboratories to design and validate laboratory developed tests (LDTs) to run on the fully automated, high-throughput platform. Laboratories can run their LDTs simultaneously with commercially available CE-IVD assays in a random access model, without waiting to batch tests.
“Rapid diagnosis is critical to combatting the spread of pandemics, and the Panther Fusion system is well suited to this purpose,” said Albert Heim, M.D, head of molecular diagnostics at Hannover Medical School. “Using inactivated virus from cell cultures and commercially available control materials, we adapted two recently published PCR protocols2 to run on the Panther Fusion system. Our next step will be to validate our assay on clinical samples.”
The emerging SARS-coronavirus-2 (SARS-CoV-2) can cause severe respiratory tract infections (COVID-19) and has been declared a public health emergency by the WHO.3,4
“It’s extremely gratifying to see our instrument system being used to quickly develop a response to an urgent public health threat,” said Kevin Thornal, president of the Diagnostic Solutions division at Hologic. “We specifically designed Panther Fusion and Open Access functionality to give diagnostic lab customers maximum flexibility, both for their day-to-day needs and to respond quickly to emerging threats.”
Users of Open Access are required to follow all applicable local requirements for their laboratory and users in developing and validating their own LDTs on the Panther Fusion system.
The Panther system launched in Europe in 2010 and in the U.S. in 2012. The Panther Fusion module, which was launched in Europe in 2016, can be attached to existing Panther systems in the field to extend testing capabilities. Specifically, the Panther Fusion module adds the capacity to run PCR assays and the Open Access functionality allows labs to develop LDTs using the platform.
The assay described in this press release has not received CE-IVD certification in Europe or clearance from the Food and Drug Administration (FDA) in the United States.
Hologic, Inc. is an innovative medical technology company primarily focused on improving women’s health and well-being through early detection and treatment. For more information on Hologic, visit www.hologic.com.
This press release may contain forward-looking information that involves risks and uncertainties, including statements about the use of Hologic’s diagnostic products. There can be no assurance these products will receive regulatory clearance in the United States or Europe, detect the SARS-coronavirus-2 effectively, meet potential demand, or achieve the benefits described herein. In addition, there can be no assurance that these products will be commercially successful or achieve any expected level of sales. Hologic expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any such statements presented herein to reflect any change in expectations or any change in events, conditions or circumstances on which any such statements are based.
Hologic, Panther, Panther Fusion, and Open Access are trademarks and/or registered trademarks of Hologic, Inc. in the United States and/or other countries.
- https://www.sciencedirect.com/science/article/pii/S1386653220300470?viewFullText=true. Accessed March 4, 2020.
- V M Corman, O Landt, M Kaiser, R Molenkamp, A Meijer, D K Chu, T Bleicker, S Brunink, J Schneider, M L Schmidt, D G Mulders, B LHaagmans, B van der Veer, S van den Brink, L Wijsman, G Goderski, J L Romette, J Ellis, M Zambon, M Peiris, H Goossens, C Reusken, M P Koopmans, and C Drosten. 2020. Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR. Euro Surveill, 25. DOI: 10.2807/1560-7917.ES.2020.25.3.2000045.
- N Zhu, D Zhang, W Wang, X Li, B Yang, J Song, et al. A Novel Coronavirus from Patients with Pneumonia in China. 2020. N Engl J Med. 382:727-733. DOI: 10.1056/NEJMoa2001017.
- T Ganzenmueller, R Kaiser, C Baier, M Wehrhane, B Hilfrich, J Witthuhn, et al. Comparison of the performance of the Panther Fusion respiratory virus panel to R-Gene and laboratory developed tests for diagnostic and hygiene screening specimens from the upper and lower respiratory tract. J Med Microbiol. (2020) In press. DOI 10.1099/jmm.0.001133.
SOURCE: Hologic, Inc.
+1 508.263.8764 (direct)
+1 585.355.5978 (mobile)
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Interactive Brokers Group Opens Singapore Office8.7.2020 02:00:00 CEST | Press release
Interactive Brokers Group (Nasdaq: IBKR), a global brokerage firm, today announced the addition of a Singapore entity Interactive Brokers Singapore Pte Ltd and the opening of an office located in the Marina Bay Financial District. With the addition of Singapore, the global brokerage firm now has nine entities around the globe in the US, Australia, Canada, Hong Kong, India, Japan, Luxembourg and the UK, serving over 876,000 clients accounts in more than 220 countries and territories. “As our client base continues to rapidly increase in Singapore, it was important to create a presence on the ground to support and service active traders and the wealth management community,” said David Friedland, Managing Director of the Asia Pacific region for Interactive Brokers. “As a critical wealth management and financial hub in Asia, our expansion in the region reflects that importance and keeps up with account growth.” Over 37% of Interactive Brokers accounts now come from Asia, up from 27% in 2017
Mary Kay Inc. Continues Its Support of Beauty, Fashion, and Design in Events Held Across Asia, Europe and the U.S.8.7.2020 00:10:00 CEST | Press release
Mary Kay Inc. and its Mary Kay Global Design Studio, recently sponsored and participated in various beauty, fashion and design events around the world with the aim of promoting the art of individual and unique beauty—and beauty artists themselves—setting the stage for the upcoming trends for the season. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200707005913/en/ Mary Kay beauty experts were on hand to tailor looks before the 27th Czech Lion Awards Show (Photo: Mary Kay) Glamhive Live & Glamhive Digital Summer Bazaar Mary Kay was the presenting sponsor for the inaugural Glamhive Live Digital Summit on May 9. Glamhive, a startup digital fashion company founded by celebrity stylist Stephanie Sprangers, allows users to receive straight-forward virtual advice from expert stylists around the world. Glamhive stylists include Tara Swennen, Ilaria Urbinati, Nicole Chavez, Jeanne Yang, Samantha McMillen, Sonia Young, Micah Schifma
FDA Authorizes Marketing of IQOS as a Modified Risk Tobacco Product7.7.2020 20:47:00 CEST | Press release
Regulatory News: The U.S. Food and Drug Administration (FDA) today authorized the marketing of IQOS, Philip Morris International’s (PMI) electrically heated tobacco system, as a modified risk tobacco product (MRTP). In doing so, the agency found that an IQOS exposure modification order is appropriate to promote the public health. - Today’s decision demonstrates that IQOS is a fundamentally different tobacco product and a better choice for adults who would otherwise continue smoking - IQOS is the first and only electronic nicotine product to be granted marketing orders through the FDA’s MRTP process - The FDA authorized the marketing of IQOS with the following information: - The IQOS System heats tobacco but does not burn it - This significantly reduces the production of harmful and potentially harmful chemicals - Scientific studies have shown that switching completely from conventional cigarettes to the IQOS system reduces your body’s exposure to harmful or potentially harmful chemical
Interactive Brokers Group to Host Second Quarter Earnings Conference Call7.7.2020 15:00:00 CEST | Press release
Interactive Brokers Group, Inc. (Nasdaq: IBKR) plans to announce its second quarter financial results on Tuesday, July 21, 2020, in a release that will be issued at approximately 4:00 pm (ET). The press release will also be available on the company's website, www.interactivebrokers.com/ir. A conference call to discuss the company's results will be held at 4:30 pm (ET) on that day, July 21. Members of the public who would like to listen to the conference call should dial 877-324-1965 (U.S. domestic) or 631-291-4512 (international). The number should be dialed approximately ten minutes prior to the start of the conference call. The conference call will also be accessible as an audio webcast through the Investor Relations section of the Interactive Brokers website, www.interactivebrokers.com/ir. About Interactive Brokers Group, Inc.: Interactive Brokers Group affiliates provide automated trade execution and custody of securities, commodities and foreign exchange around the clock on over 1
Virtual Esri User Conference to Explore How GIS Interconnects the World7.7.2020 14:41:00 CEST | Press release
Esri, the global leader in location intelligence, today announced that the 40th annual Esri User Conference will be the largest virtual gathering of GIS professionals. Normally held in San Diego, California, the conference will be presented in a completely virtual format and take place July 13–16, 2020. The Esri User Conference brings together technology innovators, executives, educators, scientists, and GIS users seeking to solve challenges in their organizations and throughout the world, using the most powerful mapping and analytics platform on the planet. This year's conference theme, GIS—Interconnecting Our World, explores how geospatial technology can integrate everything and engage everyone to overcome unprecedented global challenges. Esri founder and president Jack Dangermond will open the conference—which this year will see the Plenary Session span across three days—with his observations on how GIS, the world's nervous system, has never been more interconnected than it is today
Shippeo Extends Paperless Transportation and Advanced Pallet Scanning Capabilities to Its Real-Time Visibility Platform7.7.2020 14:18:00 CEST | Press release
Shippeo, the European leader in real-time transportation visibility solutions, has announced a new mobile application, offering a range of new capabilities. Shippeo’s mobile application allows truck drivers to manage electronic Bill of Lading via smartphone quickly and easily, unlocking the benefits of paperless administration. These include instant synchronisation with TMS for faster billing while also reducing administrative cost. In addition, electronic forms avoid paper handling, reducing hygiene concerns amid the Covid-19 pandemic. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200707005487/en/ Shippeo mobile application (Photo: Shippeo) The new Shippeo mobile application features include: Paperless proof of delivery for last mile The mobile app integrates the generation of electronic Bills of Lading (or eCMRs) capturing electronic signatures and enabling paperless proof of delivery and fasting invoicing. Delivery perso
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.Visit our pressroom